ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Embryonic stem cell factors and pancreatic cancer

Marta Herreros Villanueva; Luis Bujanda; Daniel D Billadeau; Jin San ZhangMayo Clinic College of Medicine; Mayo Clinic, College of Medicine
World Journal of Gastroenterology2014-3-7
7阅读
引用收藏
分享

摘要

Pancreatic ductal adenocarcinoma(PDAC),the most common type of pancreatic tumor,is a highly aggressive human cancer with the lowest five-year survival rate of any human maligancy primarily due to its earlymetastasis and lack of response to chemotherapy and radiation.Recent research suggests that PDAC cells comprise a hierarchy of tumor cells that develop around a population of cancer stem cells(CSCs),a small and distinct population of cancer cells that mediates tumoregenesis,metastasis and resistance to standard treatments.Thus,CSCs could be a target for more effective treatment options.Interestingly,pancreatic CSCs are subject to regulation by some of key embryonic stem cell(ESC)transctiption factors abberently expressed in PDAC,such as SOX2,OCT4 and NANOG.ESC transcription factors are important DNA-binding proteins present in both embryonic and adult somatic cells.The critical role of these factors in reprogramming processes makes them essential not only for embryonic development but also tumorigenesis.Here we provide an overview of stem cell transcription factors,particularly SOX2,OCT4,and NANOG,on their expression and function in pancreatic cancer.In contrast to embryonic stem cells,in which OCT4 and SOX2 are tightly regulated and physically interact to regulate a wide spectrum of target genes,de novo SOX2 expression alone in pancreatic cancer cells is sufficient to promote self-renewal,dedifferentiation and imparting stemness characteristics via impacting specific cell cycle regulatory genes and epithelial-mesnechymal transtion driver genes.Thus,targeting ESC factors,particularly SOX2,could be a worthy strategy for pancreatic cancer therapy.

学科与关键词

关键词
Embryonic stem cellsNANOGSOX2OCT4PluripotencyPancreatic cancerCancer stem cells
相关
加载中…
  • Detection of tumor stem cell markers in pancreatic carcinoma cell lines
    Monika Olempska; Patricia Alice Eisenach; Ole Ammerpohl; Hendrik Ungefroren; Fred Fandrich; Holger KalthoffHEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2007, (01): 92-97.
  • BRD9-SMAD2/3 Orchestrates Stemness and Tumorigenesis in Pancreatic Ductal Adenocarcinoma
    Feng, Yuliang; Cai, Liuyang; Pook, Martin; Liu, Feng; Chang, Chao-Hui; Mouti, Mai Abdel; Nibhani, Reshma; Militi, Stefania; Dunford, James; Philpott, Martin; Fan, Yanbo; Fan, Guo-Chang; Liu, Qi; Qi, Jun; Wang, Cheng; Hong, Wanzi; Morgan, Hannah; Wang, Mingyang; Sadayappan, Sakthivel; Jegga, Anil G.; Oppermann, Udo; Wang, Yigang*; Huang, Wei*; Jiang, Lei*; Pauklin, Siim*Gastroenterology, 2024, 166(1).
  • MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity (vol 39, pg 6437, 2020)
    Liang, Erbo; Lu, Yishi; Shi, Yanqiang; Zhou, Qian; Zhi, Fachao*Oncogene, 2021, 40(9): 1755-1755.
查看全部 →

发表信息

论文状态
公开发表
期刊
World Journal of Gastroenterology
发表日期
2014-03-07
卷期
第 09 期
页码
2247-2254
语言
ENGLISH
期刊收录
SCIE
期刊等级
Q2
成果收录
CHINAJOURNAL
资助标注
Supported by Universidad del Pais Vasco,Instituto Biodonostia,San Sebastian,and CIBERehd(red de enfermedades hepaticas y digestivas);American Cancer Society institutional award;Mayo Clinic Pancreatic Cancer SPORE,No.CA102701

作者

  • M

    Marta Herreros Villanueva (第一作者)

  • L

    Luis Bujanda

查看全部 4 位作者收起作者
  • D

    Daniel D Billadeau

  • J

    Jin San Zhang

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417